ArticleCancer letters2015

Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells.

Weilong Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.